Letermovir Tablets 240mg

Letermovir Tablets 240mg Technical Specification:

GENERIC NAME OF THE MEDICINAL PRODUCT:

 A) Letermovir Tablets 240mg
 B) Letermovir Tablets 480mg

QUALITATIVE AND QUANTITATIVE COMPOSITION:

A) Letermovir Tablets 240mg
Each film coated tablet contains:
Letermovir ………………………………………….240mg
Excipients…………………………………………….q.s.
Colourant: Titanium Dioxide USP, Alura Red AC
Aluminium lake: Brilliant Blue FCF Aluminium lake

B) Letermovir Tablets 480mg
Each film coated tablet contains:
Letermovir ………………………………………….480mg
Excipients…………………………………………….q.s.
Colourant: Titanium Dioxide USP, Alura Red AC
Aluminium lake: Brilliant Blue FCF Aluminium lake

THERAPEUTIC INDICATIONS:

prophylaxis (prevention) of cytomegalovirus (CMV) infection and disease in specific high-risk transplant patients.

CAUTION & WARNING:

CAUTION: Administer orally with or without food. Swallow tablets whole.

WARNING: To be sold by retail on the prescription of specialists in organ transplant, infectious disease, hematologist

STORAGE & DOSAGE:

Storage: Storage below 25°C For Oral Administration only
KEEP OUT OF REACH OF CHILDREN.

Dosage: As directed by the Physician

Introduction to Letermovir Tablets 240mg

Letermovir Tablets 240mg contain letermovir, a specialized antiviral medicine used for the prevention of cytomegalovirus (CMV) reactivation and disease in eligible transplant recipients. Unlike medicines used for herpes simplex, chickenpox, or hepatitis C, letermovir has a specific role in CMV prophylaxis, particularly in patients whose immune systems are weakened following transplantation. Regulatory information identifies letermovir for prophylaxis in appropriate recipients of allogeneic hematopoietic stem cell transplantation and certain high-risk kidney-transplant recipients.

Taj Medico is presented as a Letermovir Tablets 240mg Manufacturer in India, based in Vapi, Gujarat, serving pharmaceutical distributors, importers, institutional buyers, and international procurement companies. The 240mg tablet is especially relevant because the approved product information specifies dose adjustment when letermovir is administered with cyclosporine.

Global interest in specialized antiviral medicines is supported by the increasing need for effective infection-prevention strategies among immunocompromised patients. CMV can reactivate when immune defenses are suppressed, making appropriate prophylaxis an important part of transplant care. The European Medicines Agency describes letermovir as an antiviral that blocks the CMV terminase complex involved in viral DNA packaging.

Letermovir Tablets 240mg Manufacturer in India

As a Letermovir Tablets 240mg Supplier, we focus on pharmaceutical supply requirements that extend beyond the finished product itself. International buyers generally require consistent specifications, suitable packaging, documentation, shipment coordination, and clear commercial communication.

The 240mg strength is a film-coated tablet formulation in the authorized product information. The European product information identifies each 240mg tablet as containing 240mg of letermovir.

It is important to distinguish letermovir from other antiviral medicines. Letermovir is not indicated for herpes labialis, genital herpes, chickenpox, herpes simplex eye infections, or chronic hepatitis C. Its established indications concern CMV prophylaxis in specified transplant populations. Accurate product information is therefore essential for responsible pharmaceutical marketing and procurement.

How Letermovir 240mg Works

Letermovir works through a mechanism that differs from many conventional antiviral medicines. It inhibits the CMV terminase complex, which the virus requires for processing and packaging its DNA into newly formed viral particles.

By interfering with this viral process, letermovir prevents the development of properly formed infectious CMV particles. This mechanism supports its role as a prophylactic medicine for patients at increased risk of CMV reactivation or disease after transplantation.

Because transplant recipients may take multiple medicines simultaneously, the product’s interaction profile is particularly important. Certain medicines can alter letermovir exposure, while letermovir can also affect the exposure of other medicines. Healthcare professionals should therefore review the complete medication profile before treatment.

Letermovir Tablets 240mg Dosage Form and Product Details

The 240mg strength is available as a film-coated oral tablet in the referenced regulatory product information. For appropriate patients, the dosing regimen depends on clinical indication, body weight, concomitant medicines, and transplant status.

For adult HSCT recipients, the standard letermovir dose is generally 480mg once daily, while the dose is reduced to 240mg once daily when administered with cyclosporine. Product information should always be checked for the applicable market and patient population before dispensing or procurement.

For kidney-transplant prophylaxis, approved eligibility and duration likewise depend on the applicable regulatory labeling. EMA information describes use in CMV-seronegative recipients receiving a kidney from a CMV-seropositive donor in the relevant population.

Technical Product Specification – Letermovir Tablets 240mg

Product specifications, packaging, storage conditions, shelf life, and documentation should be confirmed against the applicable approved product specification and destination-market requirements before commercial supply.

Regulatory Documentation for Pharmaceutical Buyers

International pharmaceutical procurement requires appropriate documentation. Depending on the destination country, product registration status, transaction type, and regulatory pathway, buyers may request documents such as a Certificate of Pharmaceutical Product (COPP), Certificate of Analysis (COA), manufacturing information, product specifications, stability data, packaging details, and other quality documents.

For registration-driven markets, a CTD/eCTD dossier or equivalent technical documentation may be required. The exact dossier format depends on the importing authority and whether the product is being registered, tendered, imported under an existing authorization, or supplied through another approved pathway.

References to WHO-GMP, EU-GMP, COPP, CTD dossiers, or other certifications should be made only where the applicable facility, product, and market documentation actually supports the claim. This approach helps buyers conduct proper regulatory due diligence.

Custom Packaging and Labeling for Export

Pharmaceutical buyers frequently require market-specific packaging. Packaging and labeling may need to accommodate local language requirements, importer details, registration numbers, batch information, manufacturing and expiry dates, storage conditions, dosage information, and statutory warnings.

As a Letermovir Tablets 240mg export from India partner, we can discuss packaging requirements with buyers before order confirmation. Final artwork and labeling must comply with the regulations of the destination market and the approved product documentation.

Shelf Life, Storage, and Quality Assurance

Shelf life should always be confirmed from the specific manufactured batch and approved product documentation rather than assumed from a generic listing.

Appropriate pharmaceutical storage protects product quality throughout the supply chain. Buyers should follow the storage conditions stated on the approved label and product documentation, while distributors should maintain suitable warehousing and transportation practices.

Quality assurance begins with controlled manufacturing and extends through testing, packaging, storage, documentation, and distribution. For a specialized antiviral medicine such as letermovir, consistency across every stage is particularly important.

Why Choose Taj Medico as a Letermovir Tablets 240mg Supplier?

Taj Medico is positioned as a Letermovir Tablets 240mg Manufacturer in India, with pharmaceutical supply operations associated with Vapi, Gujarat.

We focus on providing buyers with a professional procurement experience built around product quality, communication, documentation, and supply coordination. Our approach is suitable for pharmaceutical importers, distributors, wholesalers, institutional procurement organizations, and companies evaluating international sourcing opportunities.

Our supply strengths include:

• Quality-focused pharmaceutical manufacturing
• Professional quality-control processes
• Pharmaceutical-grade production and packaging
• Export-oriented supply coordination
• Market-specific packaging discussions
• Documentation support according to applicable requirements
• Competitive commercial opportunities
• Reliable communication with international buyers
• Support for recurring pharmaceutical procurement
• Flexible coordination for distributor and institutional requirements

Letermovir Tablets 240mg PAN India Manufacturer and Supplier

Indian pharmaceutical buyers searching for a Letermovir Tablets 240mg PAN India Manufacturer, supplier, or distributor can evaluate sourcing opportunities through Taj Medico.

We can coordinate inquiries from different Indian markets, including Mumbai, Maharashtra, as well as other pharmaceutical distribution centers. Product availability, commercial pricing, order quantities, and distribution arrangements should be confirmed according to current supply status.

The phrase Letermovir Tablets 240mg Best Price in Mumbai Maharashtra may be relevant to commercial searches, but pharmaceutical buyers should compare quotations on the basis of product specifications, documentation, packaging, quality, supply reliability, and regulatory status rather than price alone.

Letermovir Tablets 240mg PCD Pharma Franchise Opportunities

Companies searching for Letermovir Tablets 240mg Manufacturer Supplier and PCD Pharma Franchise arrangements should first evaluate whether the product and proposed marketing model are permitted under the applicable regulatory framework.

Specialized prescription medicines require responsible promotion and distribution. Any franchise or distribution arrangement should therefore be structured around valid registrations, approved indications, territory requirements, and applicable pharmaceutical regulations.

We can discuss commercial requirements with eligible pharmaceutical businesses seeking long-term sourcing relationships.

Top 20 Countries and Export Markets

Our international supply strategy can serve buyers evaluating pharmaceutical procurement opportunities across:

South Africa, Kenya, Nigeria, Ghana, Tanzania, Uganda, Ethiopia, Zambia, Zimbabwe, United Arab Emirates, Saudi Arabia, Oman, Qatar, Bangladesh, Nepal, Sri Lanka, Myanmar, Vietnam, Philippines, and Cambodia.

These markets have different pharmaceutical registration, import licensing, labeling, customs, and distribution requirements. Consequently, export availability and documentation must be evaluated individually for each destination.

Letermovir Tablets 240mg Export from India

India is an important pharmaceutical manufacturing and export hub, making it a strategic sourcing location for international buyers. A reliable Letermovir Tablets 240mg export from India program requires more than shipment arrangements; it requires attention to product documentation, packaging, regulatory requirements, quality controls, logistics, and communication.

We work toward building long-term relationships with international buyers who value dependable pharmaceutical sourcing and professional export coordination.

Safety Information and Common Adverse Effects

Letermovir is a prescription medicine and should be used only according to the approved indication and instructions of a qualified healthcare professional.

Reported common adverse effects include nausea, diarrhoea, and vomiting. Other adverse reactions can occur, and clinically significant drug interactions are an important consideration.

The medicine should not be stopped, started, or dose-adjusted independently. Treatment decisions should be made by the treating physician, particularly for transplant recipients taking immunosuppressants and other medicines.

Top 20 FAQs About Letermovir Tablets 240mg

1. What are Letermovir Tablets 240mg?

They are oral film-coated tablets containing 240mg of letermovir, an antiviral medicine used for CMV prophylaxis in specified transplant populations.

2. What is letermovir used for?

Letermovir is used to prevent CMV reactivation and disease in eligible transplant recipients.

3. Is letermovir used for herpes?

No. Its established indication is CMV prophylaxis rather than routine treatment of herpes simplex or chickenpox.

4. Is letermovir an antibiotic?

No. Letermovir is an antiviral medicine.

5. What is the 240mg strength used for?

A 240mg daily regimen is used in specified situations, including when letermovir is administered with cyclosporine, according to applicable product information.

6. How does letermovir work?

It inhibits the CMV terminase complex required for viral DNA processing and packaging.

7. Who can use letermovir?

Eligibility depends on the approved indication, transplant type, CMV status, age or weight, and other clinical factors.

8. Is Letermovir Tablets 240mg available for export from India?

Commercial availability depends on current product status, regulatory requirements, and buyer specifications.

9. Who supplies Letermovir Tablets 240mg in India?

Taj Medico is positioned as a manufacturer and supplier from Vapi, Gujarat, subject to applicable product and regulatory availability.

10. Can buyers request custom packaging?

Market-specific packaging and labeling can be discussed, subject to regulatory and manufacturing requirements.

11. What documents may pharmaceutical importers require?

Depending on the market, buyers may require COA, product specifications, manufacturing documentation, COPP, stability information, and registration-related documents.

12. Is a CTD dossier required?

A CTD or equivalent dossier may be required for product registration in certain markets. Requirements vary by regulatory authority.

13. Is WHO-GMP certification important?

Yes, applicable GMP compliance is an important consideration when evaluating pharmaceutical manufacturing partners.

14. Can Letermovir Tablets 240mg be supplied PAN India?

Supply arrangements can be discussed for Indian pharmaceutical buyers according to availability and applicable distribution requirements.

15. Can Taj Medico supply international distributors?

International supply can be discussed with qualified pharmaceutical importers and distributors, subject to destination-market regulations.

16. What are common side effects?

Nausea, diarrhoea, and vomiting are among the commonly reported adverse effects.

17. Does letermovir interact with other medicines?

Yes. Clinically important interactions can occur, so healthcare professionals should review concomitant medicines before use.

18. How should letermovir be stored?

Storage should follow the conditions specified in the approved product labeling and batch documentation.

19. Is letermovir prescription-only?

Regulatory status varies by country, but the medicine is used under medical supervision and requires appropriate prescribing controls.

20. How can buyers contact a Letermovir Tablets 240mg supplier?

Pharmaceutical importers and distributors can contact Taj Medico with their required strength, quantity, destination country, packaging requirements, and documentation needs.

 Letermovir Tablets 240mg Manufacturer Supplier in India

Letermovir Tablets 240mg represent an important specialized antiviral product for CMV prophylaxis in eligible transplant recipients. Its targeted mechanism against the CMV terminase complex distinguishes it from several other antiviral medicines, while its 240mg strength has particular importance in approved dosing situations involving cyclosporine.

Taj Medico is positioned as a Letermovir Tablets 240mg Manufacturer in India, supplier, and exporter from Vapi, Gujarat, offering pharmaceutical procurement support for domestic and international buyers. Our focus remains on quality-oriented manufacturing, appropriate documentation, packaging coordination, export support, and dependable pharmaceutical supply.

For distributors, importers, pharmaceutical companies, and institutional buyers seeking Letermovir Tablets 240mg Supplier, Letermovir Tablets 240mg export from India, or a WHO-GMP manufacturer in India, Taj Medico can be approached to discuss product specifications, quantities, packaging, documentation, destination-market requirements, and commercial supply opportunities.